Two-drug regimen for HIV

The Lancet in conversation with

English - November 10, 2018 07:30 - 11 minutes - 7.69 MB
Life Sciences Science Education medicine research covid diseases science health care Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Hip replacement

Next Episode: Liver disease in the UK

Jessamy Bagenal and Kimberly Smith discuss implications arising from the Gemini study, which shows how a two-drug combination is not inferior to a conventional three-drug regimen in the treatment of HIV.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv